All Articles Tagged With: "Diabetes Drug"
Articles
FDA Rejects New Byetta Formula, Questions Health Risks and Manufacturing
The FDA has denied approval for a once-weekly version of Eli Lilly’s and Amylin Pharmaceuticals’ diabetes drug Byetta, saying that the agency needs answers to certain questions about the drug makers’ manufacturing processes and how it intends to mitigate Byetta health risks to users.
Avandia Injury Suits Could Cost Drug Maker $6B: Report
Financial analysts estimate that the pharmaceutical giant GlaxoSmithKline could face up to $6 billion in liability as a result of Avandia injury lawsuits filed over side effects of its diabetes drug, which has been linked to an increased risk of heart attacks, heart failure and other health problems.
Avandia, Seroquel Top List of Most Common Adverse Event Reports
According to a new analysis of serious, disabling and fatal adverse events reported to FDA during the third quarter of 2009, the controversial diabetes drug Avandia was associated with the most reports, followed by the antipsychotic drug Seroquel.
Glaxo Denies Concealing Avandia Heart Problems
GlaxoSmithKline PLC has released a 30-page rebuttal to a U.S. Senate report that accused the company of intentionally trying to conceal potential heart problems with Avandia, a diabetes treatment that used to be a blockbuster drug for the pharmaceutical company.
Avandia Heart Attack Risk Twice as High as Other Diabetes Drugs: Study
The results of a new study indicate that side effects of Avandia may double the risk of heart attacks when compared to other diabetes drugs.
Byetta Problems Lead Public Citizen to Recommend Avoiding Use
The consumer advocacy group Public Citizen is recommending that people avoid using the diabetes drug Byetta until at least 2012, expressing concerns about potential side effects. The recommendations come the same week the FDA announced that new information will be added to the drug’s label about reports of kidney problems with Byetta, including reports [...]
Byetta Side Effects Linked to Reports of Kidney Failure: FDA Warns
The FDA announced Monday that new labeling information will be added to the diabetes drug Byetta about reports of users who developed kidney failure and other renal problems.
Another Study Links Bone Fractures with Avandia and Actos
A new study reports that use of thiazolidinedione diabetes drugs, which include Actos and Avandia, may increase the risk of bone fractures 1.5 times, confirming the findings of early studies about the potential risk of bone fractures with Avandia and Actos.
Januvia Pancreatitis Problems Refuted by Merck
Following an FDA alert issued Friday about reports of acute pancreatitis associated with use of Januvia and Janumet, Merck & Co., the maker of both diabetes drugs, issued a statement refuting that Januvia side effects increase the risk of acute pancreatitis.
Januvia Pancreatitis Warning Updated by FDA
The FDA indicated today that the prescribing information for the diabetes drugs Januvia (sitagliptin) and Janumet (sitagliptin/metformin) will be updated to provide additional information about potential pancreatitis side effects, including reported cases of acute pancreatitis, hemorrhagic pancreatitis and necrotizing pancreatitis.
